论文部分内容阅读
目的:探讨平阳霉素治疗小儿血管瘤的治疗效果,为以后的临床工作提供一定的参考价值。方法:选取我院于2015年01月-2016年07月收治的106例血管瘤患儿。随机分为对照组和观察组,每组患者53例。对照组患儿采用地塞米松进行治疗,观察组患儿采用平阳霉素进行治疗。比较两组患儿的治疗效果及不良反应的发生情况。结果:所有患者经过治疗后观察组患者的总有效率(96.23%)明显优于对照组患者的总有效率(81.13%),差异有统计学意义(P<0.05)。结论:平阳霉素治疗小儿血管瘤的治疗效果较好,值得在临床工作中加以推广和应用。
Objective: To investigate the therapeutic effect of pingyangmycin in the treatment of pediatric hemangiomas and provide some reference value for clinical work in the future. Methods: A total of 106 hemangiomas in our hospital from January 2015 to July 2016 were selected. Randomly divided into control group and observation group, 53 cases in each group. Children in the control group were treated with dexamethasone, and children in the observation group were treated with pingyangmycin. The therapeutic effects and adverse reactions of the two groups were compared. Results: The total effective rate (96.23%) in observation group was significantly better than that in control group (81.13%) after treatment, the difference was statistically significant (P <0.05). Conclusion: Pingyangmycin treatment of pediatric hemangiomas better treatment, it is worth to be promoted in clinical work and application.